Save Search

1 to 16

Sort By:

Date Target Transaction Type
Value: $mlns
Acquirer Seller
2017-12-28 Leading Pharma
Life Science
Fairfield, New Jersey
www.leadingpharma.com

Leading Pharma is a privately-owned generic pharmaceutical company that purchases, licenses, develops, manufactures, and distributes high-quality, safe and effective products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S. Leading Pharma was founded in 2014 and is based in Fairfield, New Jersey.

Growth Capital

Signet Healthcare Partners
Investor
Growth Capital Firm
New York,
www.signethealthcarepartners.com

Crestline Investors
Investor
Asset Manager
Fort Worth, Texas
www.crestlineinvestors.com

-
2017-12-28 Aisei Pharmacy
Life Science
Tokyo, Japan
www.aisei.co.jp

Aisei Pharmacy is a pharmacy services provider. Aisei Pharmacy is a wholesaler of generic drugs. Aisei Pharmacy was founded in 1984 and is based in Tokyo, Japan.

Sold to Management -

J-STAR Co.
Investor
Asset Manager
Tokyo, Japan
www.j-star.co.jp

2017-12-26 Sucampo Pharmaceuticals, Inc.
Life Science
Bethesda, Maryland
www.sucampo.com

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of highly specialized medicines. Sucampo has a late-stage pipeline of product candidates in clinical development for orphan disease areas, including VTS-270, a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C, a rare progressive genetic disorder. VTS-270 has also been granted breakthrough therapy designation in the U.S. Sucampo has an exclusive option for the North American rights to CPP-1X/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. The company has two marketed products – AMITIZA and RESCULA.

Advisors: Cooley , Jefferies
Add-on Acquisition
Value

$1,200

Mallinckrodt
Company
Life Science
Dublin, United Kingdom
www.mallinckrodt.com

Advisors: Wachtell, Lipton, Rosen & Katz , Deutsche Bank Corporate & Investment Banking

-
Deal Article Deal Link  
2017-12-23 Discuva Ltd.
Life Science
Cambridge, United Kingdom
www.discuva.com

Discuva Ltd. is a drug discovery company. Discuva was founded in 2007 and is based in Cambridge, United Kingdom.

Add-on Acquisition

Summit Therapeutics
Company
Life Science
Miami, Florida
www.smmttx.com

-
Deal Article Deal Link  
2017-12-22 Alter Pharma
Life Science
Anderlecht, Belgium
www.alter-pharma.com

Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships. Alter Pharma is based in Anderlecht, Belgium.

Advisors: Eubelius , Jefferies
Growth Capital

Riverside
Investor
Private Equity Firm
New York, New York
www.riversidecompany.com

Advisors: A&O Shearman , Ernst & Young Capital Advisors

-
Deal Article Deal Link  
2017-12-22 BioCare Copenhagen A/S
Life Science
Copenhagen, Denmark
www.biocarecph.com

BioCare Copenhagen A/S is a provider of probiotics and specialized in microbial actives with proven health benefits, targeting gastrointestinal disorders, metabolic disorders, infections, and immunity. BioCare Copenhagen A/S was established in 2012 and is based in Copenhagen, Denmark.

Add-on Acquisition

DSM-Firmenich
Company
Chemicals
Kaiseraugst, Switzerland
www.dsm-firmenich.com

-
Deal Article Deal Link  
2017-12-22 Ignyta, Inc.
Life Science
San Diego, California
www.ignyta.com

Ignyta, Inc. is a trailblazing biotechnology company catalyzing personalized medicine with integrated Rx/Dx solutions for cancer and immunology. Ignyta was founded in 2011 and is based in San Diego, California.

Advisors: Latham & Watkins , BofA Securities , J.P. Morgan Securities
Add-on Acquisition
Value

$1,700

Roche
Company
Life Science
Basel, Switzerland
www.roche.com

Advisors: Sidley , Citi

-
Deal Article Deal Link  
2017-12-21 Precision Medicine Group
Life Science
Bethesda, Maryland
www.precisionmedicinegrp.com

Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. Precision Medicine Group was founded in 2012 and is based in Bethesda, Maryland.

Advisors: Debevoise & Plimpton , Goldman Sachs , Jefferies , Perella Weinberg Partners
Secondary Buyout

Berkshire Partners
Investor
Private Equity Firm
Boston, Massachusetts
www.berkshirepartners.com

TPG
Investor
Private Equity Firm
Fort Worth, Texas
www.tpg.com

The Blackstone Group
Investor
Private Equity Firm
New York, New York
www.blackstone.com

Advisors: Sullivan & Cromwell , BofA Securities , Barclays Investment Bank , Morgan Stanley

J.H. Whitney Capital Partners
Investor
Private Equity Firm
New Canaan, Connecticut
www.whitney.com

Deal Article Deal Link  
2017-12-21 Pasteur Group
Life Science
Andorra la Vella, Andorra
www.pasteurgroup.com

Pasteur Group is a clinical diagnostics testing provider. Pasteur Group was established in 1966 and is based in Andorra.

Add-on Acquisition

Eurofins Scientific
Company
Life Science
Luxembourg, Luxembourg
www.eurofins.com

-
Deal Link  
2017-12-21 Bio Palette
Life Science
Kobe, Japan
www.biopalette.co.jp

Bio Palette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop business in three fields, classified based on the type of cells targeted for genome editing. Bio Palette was founded in 2017 and is based in Kobe, Japan.

Venture

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

-
2017-12-20 Alizé Pharma SAS
Life Science
Ecully, France
www.alz-pharma.com

Alizé Pharma SAS is a designer and developer of livoletide. Alizé Pharma was founded in 2007 and is based in Ecully, France.

Add-on Acquisition

Millendo Therapeutics
Company
Life Science
Ann Arbor, Michigan
www.millendo.com

-
Deal Article Deal Link  
2017-12-19 Profusio GesundHeits GmbH Germany
Life Science
Greven, Germany
www.profusio.de

Profusio GesundHeits GmbH Germany is the second largest cytostatics compounder in Germany with state-of-the-art manufacturing facilities in Leipzig, Haan and Munich.

Divestiture

Zytoservice
Company
Life Science
Hamburg, Germany
www.zytoservice.de

GHD GesundHeits
Company
Medical Products
Ahrensburg, Germany
www.gesundheitsgmbh.de

Deal Article Deal Link  
2017-12-19 BIOHM Health
Life Science
Cleveland, Ohio
www.biohmhealth.com

BIOHM Health is a microbiome company guided by the cutting edge research of Dr. Mahmoud Ghannoum after his breakthrough discovery that bad bacteria and bad fungus work together to create digestive imbalance. Dr. Ghannoum realized that today's probiotics and microbiome tests had not been engineered to address the gut's total microbiome of bacteria and fungi, entirely ignoring the role fungi plays in digestive health. BIOHM Health was founded in 2016 and is based in Cleveland, Ohio.

Growth Capital

Vanterra Capital
Investor
Private Equity Firm
New York, New York
www.vanterra.com

-
Deal Article Deal Link  
2017-12-19 Wolfe Laboratories, Inc.
Life Science
Watertown, Massachusetts
www.wolfelabs.com

Wolfe Laboratories, Inc. is a premier contract research organization that provides integrated drug development solutions to the biopharmaceutical industry. Wolfe Laboratories is an essential element of the drug development ecosystem, recognized by global and virtual biopharmaceutical companies as a science-driven organization whose mission is to provide outstanding discovery and development services tailored to its clients’ needs for rational formulation development.

Add-on Acquisition

Pace
Company
Test/Measurement Equipment
Minneapolis, Minnesota
www.pacelabs.com

-
Deal Article Deal Link  
2017-12-19 RondinX Ltd.
Life Science
Tel Aviv, Israel
www.rondinx.com

RondinX Ltd. is a drug discovery platform that develops solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX Ltd. was established in 2015 and is based in Tel Aviv, Israel.

Add-on Acquisition

BiomX
Company
Life Science
Ness Ziona, Israel
www.biomx.com

-
Deal Article Deal Link  
2017-12-18 Base Pair Biotechnologies
Life Science
Houston, Texas
www.basepairbio.com

Base Pair Biotechnologies is a provider of highly customized aptamer discovery and development services. Base Pair Biotechnologies was founded in 2012 and is based in Houston, Texas.

Venture

Eventi Capital Partners
Investor
Growth Capital Firm
Toronto, Ontario
www.eventi.com

-
Deal Article Deal Link  
Avg $1,285
14.3x EBITDA
29.0x REVENUE

Try Mergr Free — Access the Full List Today

Stop Manually Tracking Deals.
Get Full Access. Cancel Anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.

Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.

The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.